These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6263974)

  • 1. Epstein Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens.
    Seeley J; Svedmyr E; Weiland O; Klein G; Moller E; Eriksson E; Andersson K; van der Waal L
    J Immunol; 1981 Jul; 127(1):293-300. PubMed ID: 6263974
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term T-cell-mediated immunity to Epstein-Barr virus.
    Rickinson AB; Moss DJ; Wallace LE; Rowe M; Misko IS; Epstein MA; Pope JH
    Cancer Res; 1981 Nov; 41(11 Pt 1):4216-21. PubMed ID: 6272965
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro.
    Moss DJ; Wallace LE; Rickinson AB; Epstein MA
    Eur J Immunol; 1981 Sep; 11(9):686-93. PubMed ID: 6170517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants.
    Wallace LE; Moss DJ; Rickinson AB; McMichael AJ; Epstein MA
    Eur J Immunol; 1981 Sep; 11(9):694-9. PubMed ID: 6271557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.
    Klein E; Masucci MG
    Springer Semin Immunopathol; 1982; 5(1):63-73. PubMed ID: 6314570
    [No Abstract]   [Full Text] [Related]  

  • 6. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
    Klein E; Ernberg I; Masucci MG; Szigeti R; Wu YT; Masucci G; Svedmyr E
    Cancer Res; 1981 Nov; 41(11 Pt 1):4210-5. PubMed ID: 6272964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell control of herpesvirus infections: lessons from the Epstein-Barr virus.
    Rickinson AB
    Prog Brain Res; 1983; 59():189-202. PubMed ID: 6320264
    [No Abstract]   [Full Text] [Related]  

  • 8. Human T-cell cultures from virus-sensitized donors can mediate virus-specific and HLA-restricted cell lysis.
    Sethi KK; Stroehmann I; Brandis H
    Nature; 1980 Aug; 286(5774):718-20. PubMed ID: 6251371
    [No Abstract]   [Full Text] [Related]  

  • 9. B lymphocytopenia in infectious mononucleosis.
    Sumaya CV; Keightley RG
    Clin Exp Immunol; 1981 Feb; 43(2):298-301. PubMed ID: 6268336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Epstein-Barr virus infects immunologic cells].
    Ernberg I; Britton S
    Lakartidningen; 1983 Feb; 80(8):689-92. PubMed ID: 6306366
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo Epstein Barr virus-induced augmentation of natural killer cell activity in the Chédiak-Higashi syndrome.
    Katz P; Zaytoun AM; Lee JH; Fauci AS
    J Immunol; 1984 Feb; 132(2):571-3. PubMed ID: 6197464
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of tinidazole on primary EBV infection and immunocompetence.
    Marklund G; Ernberg I; Britton S; Lundberg C
    Scand J Infect Dis; 1984; 16(1):17-23. PubMed ID: 6320359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious mononucleosis and Epstein-Barr virus in Japan. II. Cellular aspects.
    Takiuchi Y; Tatsumi E; Nasu K; Shirakawa S; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1981 Jul; 44(4):864-71. PubMed ID: 6277135
    [No Abstract]   [Full Text] [Related]  

  • 14. EBV specific killer T cells and serologic responses after onset of infectious mononucleosis.
    Svedmyr E; Jondal M; Henle W; Weiland O; Rombo L; Klein G
    J Clin Lab Immunol; 1978 Nov; 1(3):225-32. PubMed ID: 228038
    [No Abstract]   [Full Text] [Related]  

  • 15. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M; Myc A; Matej H; Rudzka L
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
    Sugaya N; Kimura H; Hara S; Hoshino Y; Kojima S; Morishima T; Tsurumi T; Kuzushima K
    J Infect Dis; 2004 Sep; 190(5):985-8. PubMed ID: 15295706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV-related cytotoxicity of Fc receptor negative T lymphocytes separated from the blood of infectious mononucleosis patients.
    Bakacs T; Svedmyr E; Klein E
    Cancer Lett; 1978 Apr; 4(4):185-9. PubMed ID: 206347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Education of mouse lymphocytes against human lymphoblastoid cell lines: specific recognition of determinants independent of serologically defined HLA allotypes and Epstein-Barr virus-coded antigens.
    Carnaud C; Errasti P; van der Gaag R
    Eur J Immunol; 1979 Oct; 9(10):802-8. PubMed ID: 93053
    [No Abstract]   [Full Text] [Related]  

  • 19. Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level.
    Lipinski M; Fridman WH; Tursz T; Vincent C; Pious D; Fellous M
    J Exp Med; 1979 Dec; 150(6):1310-22. PubMed ID: 229186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
    Hudnall SD; Patel J; Schwab H; Martinez J
    Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.